��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Fatal leukoencephalopathy in a patient with multiple sclerosis following treatment with ocrelizumab

Topic Multiple Sclerosis

Presentation(s) P5 - (-)

Poster/Presentation
Number 353

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Robert Kadish, MD PRESENTER	Dr. Kadish has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Kadish has received research support from Alexion Pharmaceuticals.
David A. Robertson, MD	Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Michael Sweeney, MD (University of Louisville)	Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.